Effect of obesity on the plasma lipoprotein subclass profile in normoglycemic and normolipidemic men and women

International Journal of Obesity

Volumn 32, Issue 11, 2008, Pages 1655-1664

  Magkos, F ^a,b   Mohammed, B S ^a   Mittendorfer, B ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HAROKOPIO UNIVERSITY   (Greece)

Author keywords

Lipid profile; Lipoprotein; NMR; Particle size; Sex differences; Subfractions

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERMEDIATE DENSITY LIPOPROTEIN; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; ATHEROGENESIS; BODY MASS; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; LEAN BODY WEIGHT; LIPOPROTEIN BLOOD LEVEL; MALE; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PARTICLE SIZE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; BLOOD GLUCOSE; BODY MASS INDEX; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; LIPOPROTEINS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; OBESITY; PARTICLE SIZE; RISK FACTORS; SEX FACTORS; TRIGLYCERIDES; YOUNG ADULT;

EID: 56549099576     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2008.164     Document Type: Article

References (68)

1. National Cholesterol Education Program. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report. Circulation 2002; 106: 3143-3421.
2. Kochanek KD, Murphy SL, Anderson RN, Scott C. Deaths: final data for 2002. Natl Vital Stat Rep 2004; 53: 1-115.
3. Carmena R, Duriez P, Fruchart JC. Atherogenic lipoprotein particles in atherosclerosis. Circulation 2004; 109: III2-III7.
4. Freedman DS, Otvos JD, Jeyarajah EJ, Barboriak JJ, Anderson AJ, Walker JA. Relation of lipoprotein subclasses as measured by proton nuclear magnetic resonance spectroscopy to coronary artery disease. Arterioscler Thromb Vasc Biol 1998; 18: 1046-1053.
5. Hodis HN, Mack WJ, Dunn M, Liu C, Selzer RH, Krauss RM. Intermediate-density lipoproteins and progression of carotid arterial wall intima-media thickness. Circulation 1997; 95: 2022-2026.
6. McGill Jr HC, McMahan CA. Overview of major risk factors and primary prevention of coronary heart disease. In: Fuster V, Topol EJ, Nabel EG (eds). Atherothrombosis and Coronary Artery Disease, 2 edn, Lippincott Williams & Wilkins: Philadelphia, PA, 2005, pp 23-33.
7. Howard BV, Ruotolo G, Robbins DC. Obesity and dyslipidemia. Endocrinol Metab Clin North Am 2003; 32: 855-867.
8. Hazzard WR. Atherogenesis: why women live longer than men. Geriatrics 1985; 40: 42-51, 54.
9. Halle M, Berg A, Frey I, Konig D, Keul J, Baumstark MW. Relationship between obesity and concentration and composition of low-density lipoprotein subfractions in normoinsulinemic men. Metabolism 1995; 44: 1384-1390.
10. Terry RB, Wood PD, Haskell WL, Stefanick ML, Krauss RM. Regional adiposity patterns in relation to lipids, lipoprotein cholesterol, and lipoprotein subfraction mass in men. J Clin Endocrinol Metab 1989; 68: 191-199.
11. Pascot A, Lemieux I, Prud'homme D, Tremblay A, Nadeau A, Couillard C et al. Reduced HDL particle size as an additional feature of the atherogenic dyslipidemia of abdominal obesity. J Lipid Res 2001; 42: 2007-2014.
12. MacLean PS, Bower JF, Vadlamudi S, Green T, Barakat HA. Lipoprotein subpopulation distributions in lean, obese, and type 2 diabetic women: a comparison of African and white Americans. Obes Res 2000; 8: 62-70.
13. MacLean PS, Vadlamudi S, MacDonald KG, Pories WJ, Houmard JA, Barakat HA. Impact of insulin resistance on lipoprotein subpopulation distribution in lean and morbidly obese non-diabetic women. Metabolism 2000; 49: 285-292.
14. Festa A, Williams K, Hanley AJ, Otvos JD, Goff DC, Wagenknecht LE et al. Nuclear magnetic resonance lipoprotein abnormalities in prediabetic subjects in the Insulin Resistance Atherosclerosis Study. Circulation 2005; 111: 3465-3472.
15. Campos H, Bailey SM, Gussak LS, Siles X, Ordovas JM, Schaefer EJ. Relations of body habitus, fitness level, and cardiovascular risk factors including lipoproteins and apolipoproteins in a rural and urban Costa Rican population. Arterioscler Thromb 1991; 11: 1077-1088.
16. Tian L, Jia L, Mingde F, Tian Y, Xu Y, Tian H et al. Alterations of high density lipoprotein subclasses in obese subjects. Lipids 2006; 41: 789-796.
17. Bioletto S, Golay A, Munger R, Kalix B, James RW. Acute hyperinsulinemia and very-low-density and low-density lipoprotein subfractions in obese subjects. Am J Clin Nutr 2000; 71: 443-449.
18. James RW, Brulhart-Meynet MC, Lehmann T, Golay A. Lipoprotein distribution and composition in obesity: their association with central adiposity. Int J Obes Relat Metab Disord 1997; 21: 1115-1120.
19. Li Z, McNamara JR, Fruchart JC, Luc G, Bard JM, Ordovas JM et al. Effects of gender and menopausal status on plasma lipoprotein subspecies and particle sizes. J Lipid Res 1996; 37: 1886-1896.
20. Rainwater DL, Mitchell BD, Comuzzie AG, Haffner SM. Relationship of low-density lipoprotein particle size and measures of adiposity. Int J Obes Relat Metab Disord 1999; 23: 180-189.
21. Goff Jr DC, D'Agostino Jr RB, Haffner SM, Otvos JD. Insulin resistance and adiposity influence lipoprotein size and subclass concentrations. Results from the Insulin Resistance Atherosclerosis Study. Metabolism 2005; 54: 264-270.
22. Freedman DS, Otvos JD, Jeyarajah EJ, Shalaurova I, Cupples LA, Parise H et al. Sex and age differences in lipoprotein subclasses measured by nuclear magnetic resonance spectroscopy: the Framingham Study. Clin Chem 2004; 50: 1189-1200.
23. Garvey WT, Kwon S, Zheng D, Shaughnessy S, Wallace P, Hutto A et al. Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance. Diabetes 2003; 52: 453-462.
24. Pascot A, Despres JP, Lemieux I, Almeras N, Bergeron J, Nadeau A et al. Deterioration of the metabolic risk profile in women. Respective contributions of impaired glucose tolerance and visceral fat accumulation. Diabetes Care 2001; 24: 902-908.
25. Williams PT, Krauss RM. Associations of age, adiposity, menopause, and alcohol intake with low-density lipoprotein subclasses. Arterioscler Thromb Vasc Biol 1997; 17: 1082-1090.
26. Colhoun HM, Otvos JD, Rubens MB, Taskinen MR, Underwood SR, Fuller JH. Lipoprotein subclasses and particle sizes and their relationship with coronary artery calcification in men and women with and without type 1 diabetes. Diabetes 2002; 51: 1949-1956.
27. Johnson JL, Slentz CA, Duscha BD, Samsa GP, McCartney JS, Houmard JA et al. Gender and racial differences in lipoprotein subclass distributions: the STRRIDE study. Atherosclerosis 2004; 176: 371-377.
28. Lai CQ, Corella D, Demissie S, Cupples LA, Adiconis X, Zhu Y et al. Dietary intake of n-6 fatty acids modulates effect of apolipoprotein A5 gene on plasma fasting triglycerides, remnant lipoprotein concentrations, and lipoprotein particle size: the Framingham Heart Study. Circulation 2006; 113: 2062-2070.
29. Vekic J, Topic A, Zeljkovic A, Jelic-Ivanovic Z, Spasojevic-Kalimanovska V. LDL and HDL subclasses and their relationship with Framingham risk score in middle-aged Serbian population. Clin Biochem 2007; 40: 310-316.
30. Metropolitan Life Insurance Company. 1983 Metropolitan height and weight tables. Stat Bull Metropol Life Insurance Co 1983; 64: 2-9.
31. Mittendorfer B, Patterson BW, Klein S. Effect of sex and obesity on basal VLDL-triacylglycerol kinetics. Am J Clin Nutr 2003; 77: 573-579.
32. Schectman G, Sasse E. Variability of lipid measurements: relevance for the clinician. Clin Chem 1993; 39: 1495-1503.
33. Jenkins AJ, Lyons TJ, Zheng D, Otvos JD, Lackland DT, McGee D et al. Lipoproteins in the DCCT/EDIC cohort: associations with diabetic nephropathy. Kidney Int 2003; 64: 817-828.
34. Jeyarajah EJ, Cromwell WC, Otvos JD. Lipoprotein particle analysis by nuclear magnetic resonance spectroscopy. Clin Lab Med 2006; 26: 847-870.
35. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
36. Otvos JD, Jeyarajah EJ, Bennett DW, Krauss RM. Development of a proton nuclear magnetic resonance spectroscopic method for determining plasma lipoprotein concentrations and subspecies distributions from a single, rapid measurement. Clin Chem 1992; 38: 1632-1638.
37. Chan DC, Barrett HP, Watts GF. Dyslipidemia in visceral obesity: mechanisms, implications, and therapy. Am J Cardiovasc Drugs 2004; 4: 227-246.
38. Williams PT, Vranizan KM, Austin MA, Krauss RM. Associations of age, adiposity, alcohol intake, menstrual status, and estrogen therapy with high-density lipoprotein subclasses. Arterioscler Thromb 1993; 13: 1654-1661.
39. Rivellese AA, Patti L, Kaufman D, Zhu J, Annuzzi G, Vaccaro O et al. Lipoprotein particle distribution and size, insulin resistance, and metabolic syndrome in Alaska Eskimos: The GOCADAN study. Atherosclerosis 2008, doi:10.1016/j.atherosclerosis.2007.12.041.
40. Contois J, McNamara JR, Lammi-Keefe C, Wilson PW, Massov T, Schaefer EJ. Reference intervals for plasma apolipoprotein A-1 determined with a standardized commercial immunoturbidimetric assay: results from the Framingham Offspring Study. Clin Chem 1996; 42: 507-514.
41. Jungner I, Marcovina SM, Walldius G, Holme I, Kolar W, Steiner E. Apolipoprotein B and A-I values in 147576 Swedish males and females, standardized according to the World Health Organization-International Federation of Clinical Chemistry First International Reference Materials. Clin Chem 1998; 44: 1641-1649.
42. Heiss G, Tamir I, Davis CE, Tyroler HA, Rifkand BM, Schonfeld G et al. Lipoprotein-cholesterol distributions in selected North American populations: the lipid research clinics program prevalence study. Circulation 1980; 61: 302-315.
43. Brown SA, Hutchinson R, Morrisett J, Boerwinkle E, Davis CE, Gotto Jr AM et al. Plasma lipid, lipoprotein cholesterol, and apoprotein distributions in selected US communities. The Atherosclerosis Risk in Communities (ARIC) Study. Arterioscler Thromb 1993; 13: 1139-1158.
44. Jenkins AJ, Lyons TJ, Zheng D, Otvos JD, Lackland DT, McGee D et al. Serum lipoproteins in the diabetes control and complications trial/epidemiology of diabetes intervention and complications cohort: associations with gender and glycemia. Diabetes Care 2003; 26: 810-818.
45. McNamara JR, Campos H, Ordovas JM, Peterson J, Wilson PW, Schaefer EJ. Effect of gender, age, and lipid status on low density lipoprotein subfraction distribution. Results from the Framingham Offspring Study. Arteriosclerosis 1987; 7: 483-490.
46. Campos H, Blijlevens E, McNamara JR, Ordovas JM, Posner BM, Wilson PW et al. LDL particle size distribution. Results from the Framingham Offspring Study. Arterioscler Thromb 1992; 12: 1410-1419.
47. Carr MC, Hokanson JE, Zambon A, Deeb SS, Barrett PH, Purnell JQ et al. The contribution of intraabdominal fat to gender differences in hepatic lipase activity and low/high density lipoprotein heterogeneity. J Clin Endocrinol Metab 2001; 86: 2831-2837.
48. Lemieux I, Pascot A, Lamarche B, Prud'homme D, Nadeau A, Bergeron J et al. Is the gender difference in LDL size explained by the metabolic complications of visceral obesity? Eur J Clin Invest 2002; 32: 909-917.
49. Nikkila M, Pitkajarvi T, Koivula T, Solakivi T, Lehtimaki T, Laippala P et al. Women have a larger and less atherogenic low density lipoprotein particle size than men. Atherosclerosis 1996; 119: 181-190.
50. Haffner SM, D'Agostino Jr R, Goff D, Howard B, Festa A, Saad MF et al. LDL size in African Americans, Hispanics, and non-Hispanic whites: the insulin resistance atherosclerosis study. Arterioscler Thromb Vasc Biol 1999; 19: 2234-2240.
51. Watson TD, Caslake MJ, Freeman DJ, Griffin BA, Hinnie J, Packard CJ et al. Determinants of LDL subfraction distribution and concentrations in young normolipidemic subjects. Arterioscler Thromb 1994; 14: 902-910.
52. Festa A, D'Agostino Jr R, Mykkanen L, Tracy RP, Hales CN, Howard BV et al. LDL particle size in relation to insulin, proinsulin, and insulin sensitivity. The Insulin Resistance Atherosclerosis Study. Diabetes Care 1999; 22: 1688-1693.
53. Haffner SM, Mykkanen L, Stern MP, Paidi M, Howard BV. Greater effect of diabetes on LDL size in women than in men. Diabetes Care 1994; 17: 1164-1171.
54. Tan CE, Foster L, Caslake MJ, Bedford D, Watson TD, McConnell M et al. Relations between plasma lipids and postheparin plasma lipases and VLDL and LDL subfraction patterns in normolipemic men and women. Arterioscler Thromb Vasc Biol 1995; 15: 1839-1848.
55. Kazumi T, Kawaguchi A, Hozumi T, Nagao M, Iwahashi M, Hayakawa M et al. Low density lipoprotein particle diameter in young, nonobese, normolipidemic Japanese men. Atherosclerosis 1999; 142: 113-119.
56. Ooi EM, Watts GF, Farvid MS, Chan DC, Allen MC, Zilko SR et al. High-density lipoprotein apolipoprotein A-I kinetics in obesity. Obes Res 2005; 13: 1008-1016.
57. Egusa G, Beltz WF, Grundy SM, Howard BV. Influence of obesity on the metabolism of apolipoprotein B in humans. J Clin Invest 1985; 76: 596-603.
58. Howard BV, Egusa G, Beltz WF, Kesaniemi YA, Grundy SM. Compensatory mechanisms governing the concentration of plasma low density lipoprotein. J Lipid Res 1986; 27: 11-20.
59. Kesaniemi YA, Beltz WF, Grundy SM. Comparisons of metabolism of apolipoprotein B in normal subjects, obese patients, and patients with coronary heart disease. J Clin Invest 1985; 76: 586-595.
60. Watts GF, Moroz P, Barrett PH. Kinetics of very-low-density lipoprotein apolipoprotein B-100 in normolipidemic subjects: pooled analysis of stable-isotope studies. Metabolism 2000; 49: 1204-1210.
61. Magkos F, Patterson BW, Mohammed BS, Klein S, Mittendorfer B. Women produce fewer but triglyceride-richer very low density lipoproteins than men. J Clin Endocrinol Metab 2007; 92: 1311-1318.
62. Welty FK, Lichtenstein AH, Barrett PH, Dolnikowski GG, Schaefer EJ. Interrelationships between human apolipoprotein A-I and apolipoproteins B-48 and B-100 kinetics using stable isotopes. Arterioscler Thromb Vasc Biol 2004; 24: 1703-1707.
63. Welty FK, Lichtenstein AH, Barrett PH, Dolnikowski GG, Schaefer EJ. Human apolipoprotein (Apo) B-48 and ApoB-100 kinetics with stable isotopes. Arterioscler Thromb Vasc Biol 1999; 19: 2966-2974.
64. Brinton EA, Eisenberg S, Breslow JL. Human HDL cholesterol levels are determined by apoA-I fractional catabolic rate, which correlates inversely with estimates of HDL particle size. Effects of gender, hepatic and lipoprotein lipases, triglyceride and insulin levels, and body fat distribution. Arterioscler Thromb 1994; 14: 707-720.
65. Welty FK, Lichtenstein AH, Lamon-Fava S, Schaefer EJ, Marsh JB. Effect of body mass index on apolipoprotein A-I kinetics in middle-aged men and postmenopausal women. Metabolism 2007; 56: 910-914.
66. Tilly-Kiesi M, Lichtenstein AH, Joven J, Vilella E, Cheung MC, Carrasco WV et al. Impact of gender on the metabolism of apolipoprotein A-I in HDL subclasses LpAI and LpAI:AII in older subjects. Arterioscler Thromb Vasc Biol 1997; 17: 3513-3518.
67. Ooi EM, Watts GF, Farvid MS, Chan DC, Allen MC, Zilko SR et al. High-density lipoprotein apolipoprotein A-I kinetics: comparison of radioactive and stable isotope studies. Eur J Clin Invest 2006; 36: 626-632.
68. 3]leucine in middle-aged and elderly men and women. Arterioscler Thromb Vasc Biol 2000; 20: 801-806.